To view or add a comment, sign in More Relevant Posts Editor's Choice: This review highlights the latest evidence-based approaches to #obesity management, spanning behavioral, nutritional, pharmacologic, and surgical interventions
The United States, in particular, represents a large market for GLP-1 receptor agonists, driven by the presence of key pharmaceutical players and high levels of healthcare investment
2021 Aug 9;13(1):125
Novo Nordisk's FlexPen auto-injector and Eli Lilly's single-use pen devices have made once-weekly self-injection practical for most patients, with injection site reactions generally mild and transient
GLP-1 medications should not be taken by people with a history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2
Trends Endocrinol Metab (2020) 31:8902